Recent News

Timber Pharmaceuticals, Inc., (NYSE American: TMBR), formerly known as BioPharmX Corporation ("Timber" or the "Company"), a biopharmaceutical...

Timber Pharmaceuticals LLC ("Timber"), a privately held biopharmaceutical company focused on the development and commercialization of...

Timber Pharmaceuticals LLC ("Timber"), a privately held biopharmaceutical company focused on the development...

Two privately held biotechs on Tuesday announced plans for reverse mergers, transactions that provide a faster...

AFT Pharmaceuticals (NZX.AFT, ASX.AFP) has reached an out-licensing and development agreement with US-based Timber Pharmaceuticals [Timber] for...

BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX") and Timber Pharmaceuticals LLC ("Timber"), a privately held biopharmaceutical...